MedTrace Logo

Magnetic Resonance Imaging in the Diagnosis of Pulmonary Hypertension

NCT00575692 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2014-05-28

No results posted yet for this study

Summary

The aim of the present study is to identify changes in the cardiovascular system in patients with pulmonary hypertension (PH) by magnetic resonance imaging (MRI). MRI is accepted as golden standard method for the evaluation of left and right ventricular morphology and function.

All patients who showed elevated pulmonary pressure in the right heart catheter investigation are assigned to MRI. Parameters derived from MRI are included in the clinical and therapeutic decisions. Well established as well as new MRI parameters are evaluated and compared to the results of right heart catheter. Further age-matched controls without known cardiac or pulmonary disease are investigated by native MRI.

Conditions

  • Pulmonary Hypertension
  • Ventricular Function
  • MR Phase Contrast Velocity Imaging
  • Late Enhancement Patterns

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Gabor Kovacs, MD · Medical Unitersity Graz, University Clinic of Internal Medicine, Department of Pulmonology

  • Ursula Reiter, PhD · Medical Unitersity Graz, University Clinic of Radiology, Department of General Radiological Diagnostics

  • Gert Reiter, PhD · Siemens Medical Austria

  • HOrst Olschewski, M.D. · Medical University of Graz

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00575692 on ClinicalTrials.gov